MHRA seeks input on AI regulation at ‘pivotal moment’ for healthcare

Ensuring the seasonal flu vaccine is ready, safe and effective involves months of international planning, testing and collaboration

An Expert Working Group has completed a review into how the potential risks associated with antidepressant medicines are communicated to patients

These reports outline the MHRA’s Corporate and Business Plans, detailing the agency’s strategic direction over the next three years.

The tenth annual #MedSafetyWeek brings together more than 130 medicines regulators and health organisations across 117 countries to encourage people to report suspected side effects from medicines and device incidents.

Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure due to a potential error at the manufacturing site.

With all complex clinical trials, MHRA’s top priority is the safety and wellbeing of the trial participants